PFG Advisors Has $3.88 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

PFG Advisors increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,559 shares of the healthcare conglomerate’s stock after buying an additional 222 shares during the quarter. PFG Advisors’ holdings in UnitedHealth Group were worth $3,882,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Mechanics Bank Trust Department lifted its position in shares of UnitedHealth Group by 4.2% during the 2nd quarter. Mechanics Bank Trust Department now owns 7,421 shares of the healthcare conglomerate’s stock worth $3,811,000 after buying an additional 302 shares during the period. Guardian Financial Partners LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at $216,000. Stokes Capital Advisors LLC raised its position in UnitedHealth Group by 1.8% in the 2nd quarter. Stokes Capital Advisors LLC now owns 15,107 shares of the healthcare conglomerate’s stock valued at $7,760,000 after purchasing an additional 265 shares during the last quarter. Castle Rock Wealth Management LLC raised its position in UnitedHealth Group by 2.1% in the 2nd quarter. Castle Rock Wealth Management LLC now owns 1,939 shares of the healthcare conglomerate’s stock valued at $997,000 after purchasing an additional 39 shares during the last quarter. Finally, Bridge Advisory LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at $236,000. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Stock Up 1.1 %

NYSE:UNH opened at $517.46 on Friday. The stock has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. The stock has a 50-day moving average price of $530.11 and a two-hundred day moving average price of $512.45. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same period in the previous year, the company posted $4.70 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were issued a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.28%. UnitedHealth Group’s payout ratio is presently 34.46%.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Raymond James lifted their price objective on UnitedHealth Group from $620.00 to $635.00 in a research report on Thursday. Credit Suisse Group lifted their target price on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Argus lifted their target price on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a research note on Monday, July 25th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $586.40.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now owns 76,559 shares in the company, valued at $40,415,496.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 139,051 shares of company stock worth $74,450,958. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.